Heparin-induced thrombocytopenia physical examination
Heparin-induced thrombocytopenia |
Differentiating Heparin-induced thrombocytopenia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Heparin-induced thrombocytopenia physical examination On the Web |
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia physical examination |
FDA on Heparin-induced thrombocytopenia physical examination |
CDC on Heparin-induced thrombocytopenia physical examination |
Heparin-induced thrombocytopenia physical examination in the news |
Blogs on Heparin-induced thrombocytopenia physical examination |
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
Risk calculators and risk factors for Heparin-induced thrombocytopenia physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]
Overview
The physical exam for HIT focuses on the skin, pulmonary, and musculoskeletal exam. These are the common areas of thrombotic manifestations. Bleeding can also occur in these organs. A complete physical exam can help with evaluation of thrombosis or bleeding in other organs.
Physical Examination
Skin Exam
Appearance of the Patient
- Patients with heparin induced thrombocytopenia usually appear flushed.
Vital Signs
- Fever
- Chill
- Tachycardia
- Tachypnea
Skin
- Skin necrosis from thrombotic physiology[1][2]
- Petechiae from thrombocytopenia
- Purpura from thrombocytopenia
- Ecchymoses from thrombocytopenia
HEENT
- HEENT examination of patients with heparin induced thrombocytopenia is usually normal.
Neck
- Neck examination of patients with heparin induced thrombocytopenia is usually normal.
Lungs
- Pulmonary examination of patients with heparin induced thrombocytopenia is usually normal.
Heart
- Tachypnea from pulmonary embolism
- Tachycardia from pulmonary embolism
- Hypoxia from pulmonary embolism
Musculoskeletal Exam
- Leg swelling from deep vein thrombosis[1]
- Calf tenderness from deep vein thrombosis
Other Exam Findings
- Mucosal bleeding from thrombocytopenia (i.e. oral, nasal, urinary, menstrual, gastrointestinal, or other)
- Abdominal tenderness from mesenteric venous thrombosis
- Neurologic deficits from cerebral arterial or dural venous sinus thrombosis
Reference
- ↑ 1.0 1.1 Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S; et al. (2012). "Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. 141 (2 Suppl): e495S–e530S. doi:10.1378/chest.11-2303. PMC 3278058. PMID 22315270.
- ↑ McKenzie SE, Sachais BS (2014). "Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia". Curr Opin Hematol. 21 (5): 380–7. doi:10.1097/MOH.0000000000000066. PMC 4232774. PMID 24992313.